chr16-11679740-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015914.7(TXNDC11):c.2332C>A(p.Gln778Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015914.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNDC11 | NM_015914.7 | c.2332C>A | p.Gln778Lys | missense_variant | 12/12 | ENST00000283033.10 | NP_056998.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNDC11 | ENST00000283033.10 | c.2332C>A | p.Gln778Lys | missense_variant | 12/12 | 2 | NM_015914.7 | ENSP00000283033.5 | ||
TXNDC11 | ENST00000356957.7 | c.2413C>A | p.Gln805Lys | missense_variant | 13/13 | 1 | ENSP00000349439.3 | |||
TXNDC11 | ENST00000570917.5 | n.542C>A | non_coding_transcript_exon_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251478Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135916
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.0000743 AC XY: 54AN XY: 727236
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | The c.2332C>A (p.Q778K) alteration is located in exon 12 (coding exon 12) of the TXNDC11 gene. This alteration results from a C to A substitution at nucleotide position 2332, causing the glutamine (Q) at amino acid position 778 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at